BRA is usually detected during routine prenatal care. The most common sign is oligohydramnios, which can lead to Potter's sequence—a series of physical deformities caused by the lack of amniotic fluid. These may include facial anomalies, limb deformities, and underdeveloped lungs. In some cases, BRA may be associated with other congenital anomalies affecting the heart, spine, or gastrointestinal tract.

The diagnosis of BRA is primarily made through prenatal imaging, such as ultrasound, which can reveal the absence of kidneys and reduced amniotic fluid. Further imaging, like MRI, may be used to confirm the diagnosis. Genetic testing might be conducted to identify any underlying genetic causes or associated syndromes. In some cases, a detailed family history is taken to assess any hereditary patterns.

Currently, there is no treatment available to replace the missing kidneys in utero. Management focuses on supportive care and addressing any associated anomalies. In some cases, experimental treatments like amnioinfusion, where saline is injected into the amniotic sac, have been attempted to improve lung development. Postnatal care, if the infant survives birth, involves managing complications and providing supportive care.

The prognosis for BRA is generally poor. The absence of kidneys leads to severe complications, primarily due to underdeveloped lungs, which are critical for survival after birth. Most infants with BRA are stillborn or die shortly after birth due to respiratory failure. In rare cases, if the condition is part of a syndrome with less severe manifestations, survival may be possible with intensive medical intervention.

The exact cause of BRA is not fully understood, but it is believed to result from genetic and environmental factors. Mutations in certain genes involved in kidney development have been identified in some cases. Additionally, BRA can occur as part of a syndrome, such as Fraser syndrome, which involves multiple congenital anomalies.

BRA is a rare condition, occurring in approximately 1 in 3,000 to 1 in 10,000 births. It affects both males and females equally and has been reported in various populations worldwide. The rarity of the condition makes it a significant focus of research to better understand its causes and potential interventions.

The pathophysiology of BRA involves the failure of the metanephric blastema, a cluster of cells that give rise to the kidneys, to develop during fetal growth. This failure leads to the absence of kidneys and subsequently, a lack of urine production, which is a major component of amniotic fluid. The resulting oligohydramnios affects fetal development, particularly the lungs, leading to the complications seen in Potter's sequence.

Currently, there are no known preventive measures for BRA due to its complex genetic and environmental causes. Genetic counseling may be offered to families with a history of the condition to assess the risk in future pregnancies. Ongoing research aims to identify potential risk factors and develop preventive strategies.

Bilateral Renal Agenesis is a rare and serious congenital condition characterized by the absence of both kidneys in a fetus. It leads to a lack of amniotic fluid and associated developmental issues, primarily affecting the lungs. Diagnosis is typically made through prenatal imaging, and while there is no cure, supportive care is provided. The condition has a poor prognosis, with most affected infants not surviving past birth.

For families affected by BRA, understanding the condition can be challenging. It is important to know that BRA is a rare congenital disorder where a baby is born without kidneys. This leads to a lack of amniotic fluid, which is essential for the baby's development, especially the lungs. While there is no treatment to replace the kidneys, medical teams focus on providing the best possible care and support. Genetic counseling may be helpful for families to understand the condition and assess future risks.